Slide 1: Submission of Investor Presentation cover letter
Manufacturer & Exporters of Essential Oils & Aromatics Chemicals Registered Office: A/410-411, A-Wing, Kailash Ind. Complex, Powai Vikhroli link Rd, Vikhroli West, Mumbai-400079. Maharashtra, India, Tel No: +91-2225185231/25185931 CIN: L24246MH1997PLC111057 Date: May 21, 2026 To, To, Listing / Compl
Slide 2: Investor Presentation Q4 & FY26
Investor Presentation Q4 & FY26
Slide 3: Disclaimer
Disclaimer This presentation and the accompanying slides (the “Presentation”), has been prepared by Gem Aromatics Ltd (the “Company”), solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any securities, and shall not form the bas
Slide 4: Table of Contents
Table of Contents Q4 & FY26 Highlights Company Overview Annexure 3
Slide 5: Q4 & FY26 Highlights
AROMATICS Q4 & FY26 Highlights Ci GEM
Slide 6: Management Commentary
Management Commentary The quarter witnessed a meaningful improvement in the operating environment, supported by reduction and better clarity on USA tariffs. Backed by improving customer engagement, stronger demand across key markets, better volumes, and improved price realization, the Company delive
Slide 7: Sequential Improvement in Financial Performance
Sequential Improvement in Financial Performance Revenue Gross Margin & PAT Cash PAT (Rs Cr) EBITDA Margin (%) (Rs Cr) (Rs Cr) 23.4 % Standalone (Gross Margin improved from Rs 112 Cr 18.4% in Q3FY26) Rs 12 Cr Rs 13 Cr 34% QoQ 13.4 % 182% QoQ 114% QoQ (EBITDA Margin improved from 9.1% in Q3FY26)
Slide 8: Key Business Updates
Key Business Updates Revenue & Market Environment Q4FY26 witnessed gradual recovery in domestic and global demand, supported by better clarity on USA tariffs and improving trade conditions, leading to better volumes and improved price realization. Gross Margin & EBITDA Margin Gross margin and EBITDA
Slide 9: Standalone Profit & Loss Statement
Standalone Profit & Loss Statement Particulars (Rs Cr) Q4FY26 Q4FY25 YoY (%) Q3FY26 QoQ (%) FY26 FY25 YoY (%) Net Revenue From Operations 112.2 206.3 -45.6% 83.9 33.8% 370.9 497.0 -25.4% Cost of Goods Sold 86.0 147.1 68.5 296.4 377.0 Gross Profit 26.2 59.1 -55.7% 15.4 70.2% 74.5 120.0 -37.9% Gross P
Slide 10: Consolidated Profit & Loss Statement
Consolidated Profit & Loss Statement Particulars (Rs Cr) Q4FY26 Q4FY25 YoY (%) Q3FY26 QoQ (%) FY26 FY25 YoY (%) Net Revenue From Operations 110.4 202.2 -45.4% 78.9 39.9% 366.5 504.0 -27.3% Cost of Goods Sold 76.7 147.9 59.0 276.1 378.7 Gross Profit 33.7 54.3 -37.9% 19.9 69.6% 90.3 125.2 -27.9% Gross
Slide 11: Consolidated Balance Sheet
Consolidated Balance Sheet Liabilities (Rs Cr) Mar-25 Mar-26 Assets (Rs Cr) Mar-25 Mar-26 Property, Plant & Equipment and Share Capital 9.4 10.4 43.4 243.1 Intangible Assets Reserves & Surplus 274.6 439.5 Capital Works-in-progress 125.5 6.1 Shareholders' Funds 284.0 449.9 Right To Use Assets 11.0 10
Slide 12: Consolidated Cash Flow Statement
Consolidated Cash Flow Statement Particulars (Rs Cr) FY25 FY26 Net Profit Before Tax and Extraordinary Items 74.4 6.4 Adjustments for: Non-Cash Items / Other Investment or Financial Items 15.4 40.1 Operating Profit Before Working Capital Changes 89.8 46.4 Changes in Working Capital -89.5 -5.5 Cash G
Slide 13: Greenfield Project at Dahej with 10,871 MTPA Capacity
Fueling Future Growth – Greenfield Project at Dahej with 10,871 MTPA Capacity Key Plant Highlights Key Business Update Krystal Ingredients Pvt. Ltd. ✓ During Q4 FY26, commercial production of GEM Cool 5 cooling agents and Safranal commenced. Wholly owned subsidiary ✓ This completes the Company’s int
Slide 14: Company Overview
AROMATICS Company Overview 6 GEM
Slide 15: A Journey of 3 Decades leading to Growth and Transformation
~A Journey of 3 Decades leading to Growth and Transformation… 1997 2008 2009 2013 2016 2018 Executed the first Introduced a new Received Star Export Commenced production Incorporated our Achieved Rs 1,648 mn in export order vertical – Clove oil House status at Unit II – Budaun, U.P Company and reven
Slide 16: Established Scale with a Strong Market Presence
…Established Scale with a Strong Market Presence • One of the leading Indian manufacturer of specialty ingredients, including essential oils, aroma chemicals, and value-added derivatives. • Company offers a wide range of products across Mint, Clove, Phenol, and other natural and synthetic ingredient
Slide 17: Mint & Mint Derivative – Well Established Business
Mint & Mint Derivative – Well Established Business • Largest business segment with strong customer demand • Widely used in Oral Care, Pharma, Nutraceuticals, Personal Care, Wellness • With a facility in the Budaun mint belt (UP), we benefit from easy, cost-efficient access to quality mint raw materi
Slide 18: Clove & Clove Derivatives – High-Value Segment
Clove & Clove Derivatives – High-Value Segment with Leadership in Eugenol • Second-largest Revenue contributor with Strong Margin Profile • One of the largest processors of Clove Oil and Eugenol (by volume in India, FY25) • Used in Flavor, Dental Care, Pharma, Fragrance Applications Products Growth
Slide 19: Entering Advanced Chemistry with Phenol Derivatives
Entering Advanced Chemistry with Phenol Derivatives • Diversified phenolic portfolio serving pharma, antioxidant and fragrance applications. • Sustainable vapor-phase technology ensures high-purity output with near-zero effluent. • Forward-integrated processes enable entry into limited-competition,
Slide 20: Citral Chemistry and Other Natural & Synthetic Ingredients
Citral Chemistry (New Products) and Other Natural & Synthetic Ingredients Natural & Synthetic • Largest processor of Eucalyptus Oil in India with ~58% Citral Chemistry Ingredients market share (FY25)* New Products Entering into High-Value Aroma Molecules • Diversified sourcing of crude eucalyptus &
Slide 21: Focus on Growing Value-Added Products
Focus on Growing Value-Added Products – From Base to Advanced Molecules Category Mother Ingredient/ Base Product Advanced / Specialty Products Industry Peppermint Mint & Mint Spearmint Cooling Agents – 05, WS 03 • Oral Care Derivatives Menthol • Cosmetics Clove & Clove Eugenol • Nutraceuticals Clove
Slide 22: Experienced Promoters and Management Team (1/3)
Experienced Promoters and Management Team…(1/3) Promoters and Directors Vipul Parekh Kaksha Vipul Parekh Yash Vipul Parekh Whole-Time Director Whole-Time Director, Chairperson and CFO Managing Director and Chief Executive Officer • Associated with the company since inception • Associated with the co
Slide 23: Experienced Promoters and Management Team (2/3)
Experienced Promoters and Management Team…(2/3) Dinesh T V Shrenik Vora Additional Whole-Time Director Non-Executive Director • Associated with the company since inception • Chartered Accountant with 25+ years of experience in financial services. • M.Sc. in Chemistry from University of Calicut • For
Slide 24: Experienced Promoters and Management Team (3/3)
Experienced Promoters and Management Team…(3/3) Independent Directors KMP and SMP Dr. Kiran Sirsalmath General Manager – R&D • Ph.D. in Chemistry from Karnatak University. • Leads R&D, innovation, and new product development. CA Nandan Narula Dr. Ajay Sahai Vishakha Bhagvat Dr. Parag Gogate Dr. Shub
Slide 25: Strategically Located Manufacturing Facilities
Strategically Located Manufacturing Facilities with Advanced Capabilities Dahej Access to Phenol and Excellent Connectivity via Budaun Expressway and Located in India’s Ports. prime Mint Silvassa Facility Budaun Facility Dahej Facility Cultivation Belt. (1997) (2016) (2024) Capacity Capacity Capacit
Slide 26: From India to the World: Strengthening Our Global Presence
From India to the World: Strengthening Our Global Presence Serving 225 domestic and Germany Moldova 44 international customers Bulgaria United across 20 countries Kingdom USA Ireland Netherlands France Turkey China Strategic investor Israel Hong Kong and customer Spain Vietnam Italy Thailand Uganda
Slide 27: Complex Chemistries Process Technology
With Complex and Advanced End-to-End Processes Journey of a Molecule Raw Material Arrival Extraction & Isolation Complex Chemistry In-Action Automated Quality & Analytics Final Formulation & Packaging Quality checked, tracked, and Botanicals and petrochemicals Breakthrough molecules and derivatives
Slide 28: Strong and Robust R&D Capabilities Driving Innovation
Strong and Robust R&D Capabilities Driving Innovation Structured R&D Focus Areas Existing Product Innovation: Portfolio Expansion: Strategic Market Targeting: ✓ Improving yields, selectivity, and process ✓ New molecules, new chemistry, and step ✓ Identifying high-demand products with limited efficie
Slide 29: Annexure
Annexure AROMATICS
Slide 30: Dahej Plant Pictures
|| Dahej Plant Pictures 29
Slide 31: Stock Information & Shareholding Pattern
Stock Information & Shareholding Pattern Capital Market Information (as on 21st May 2026) Shareholding Pattern (as on 31st March 2026) BSE/NSE Code 544491/ GEMAROMA Public Promoters 37.1% 57.0% CMP (Rs) 160.05 Market Cap (Rs Cr) 833.18 Shares (Cr) 5.22 DII's 4.8% FII's Face Value (Rs) 2.00 1.1% 30
Slide 32: Thank You
Thank You Gem Aromatics Ltd Stellar IR Advisors Pvt. Ltd. CIN No. L24246MH1997PLC111057 Akshita Gohil Akhilesh Gandhi, CFA | akhilesh@stellar-ir.com secretarial@gemaromatics.in Omkar Sawant| omkar@stellar-ir.com Phone: 9322121990 | 022 25185231 Phone: 022 62398024 www.gemaromatics.com www.stellar-ir